.Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China .Department of Transfusion Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China
Abstract：Objective To study the clinical features of children with carbapenem-resistant Enterobacterales (CRE) infection and the molecular characteristics of isolated strains. Methods A retrospective analysis was performed on the clinical data and infection status of the children who were hospitalized in Guangdong Provincial People's Hospital from January 2018 to June 2021. A total of 1 098 non-repetitive strains of Enterobacterales were obtained. Drug sensitivity test, PCR amplification, and resistance-related gene sequencing were performed for 66 isolated CRE strains to observe molecular epidemiology. Results Among the 1 098 strains of Enterobacterales, the detection rate of CRE was 6.01% (66/1 098). The 66 CRE strains were isolated from 66 children, among whom there were 37 boys (56%) and 29 girls (44%), with an age of 2 days to 14 years. Among these 66 children, 16 (24%) had an age of <1 month, 28 (42%) had an age of 1-12 months, 11 (17%) had an age of 12-36 months, and 11 (17%) had an age of >36 months. The children with CRE were mainly distributed in the department of neonatology (38 children, 58%) and the pediatric intensive care unit (17 children, 26%). The top three types of specimens with CRE detection were respiratory specimens (48%), midstream urine specimens (21%), and blood specimens (17%). The CRE strains were mainly Klebsiella pneumoniae (45 strains, 68%), Escherichia coli (12 strains, 18%), and Enterobacter cloacae (6 strains, 9%), with high resistance to carbapenems (such as imipenem and ertapenem), penicillin, and cephalosporins, slightly high resistance to commonly used antibiotics, and relatively low resistance to amikacin (14%), levofloxacin (23%), and tobramycin (33%). The carbapenemase genotypes of Klebsiella pneumoniae strains were mainly blaNDM (20 strains, 44%), blaIMP (10 strains, 22%), and blaKPC (5 strains, 11%), and the carbapenemase genotypes of Escherichia coli strains were mainly blaNDM (10 strains, 83%). After sequencing, there were 24 blaNDM-1 strains, 6 blaNDM-5 strains, 5 blaIMP-4 strains, and 3 blaKPC-2 strains, and some genotypes were not identified. Conclusions There is a high incidence rate of CRE infection among children, mainly those aged 1-12 months. CRE generally has high resistance to antibacterial drugs, and metalloenzymes are the main type of carbapenemases for CRE strains in children.
YE Long,ZHANG Li-Yan,ZHAO Yue et al. Clinical features and molecular epidemiology of carbapenem-resistant Enterobacterales infection in children[J]. CJCP, 2022, 24(8): 881-886.
Brennan-Krohn T, Manetsch R, O'Doherty GA, et al. New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae[J]. Transl Res, 2020, 220: 14-32. PMID: 32201344. PMCID: PMC7293954. DOI: 10.1016/j.trsl.2020.02.008.
Dallenne C, Da Costa A, Decré D, et al. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae[J]. J Antimicrob Chemother, 2010, 65(3): 490-495. PMID: 20071363. DOI: 10.1093/jac/dkp498.
Mrowiec P, Klesiewicz K, Ma?ek M, et al. Antimicrobial susceptibility and prevalence of extended-spectrum beta-lactamases in clinical strains of Klebsiella pneumoniae isolated from pediatric and adult patients of two Polish hospitals[J]. New Microbiol, 2019, 42(4): 197-204. PMID: 31609454.
Rozaidi SW, Sukro J, Dan A. The incidence of nosocomial infection in the Intensive Care Unit, Hospital Universiti Kebangsaan Malaysia: ICU-acquired nosocomial infection surveillance program 1998-1999[J]. Med J Malaysia, 2001, 56(2): 207-222. PMID: 11771082.
Dong F, Zhang Y, Yao K, et al. Epidemiology of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in a Chinese children's hospital: predominance of New Delhi metallo-β-lactamase-1[J]. Microb Drug Resist, 2018, 24(2): 154-160. PMID: 28594635. DOI: 10.1089/mdr.2017.0031.
Zhang X, Chen D, Xu G, et al. Molecular epidemiology and drug resistant mechanism in carbapenem-resistant Klebsiella pneumoniae isolated from pediatric patients in Shanghai, China[J]. PLoS One, 2018, 13(3): e0194000. PMID: 29558475. PMCID: PMC5860732. DOI: 10.1371/journal.pone.0194000.
Alatoom A, Elsayed H, Lawlor K, et al. Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa[J]. Int J Infect Dis, 2017, 62: 39-43. PMID: 28610832. DOI: 10.1016/j.ijid.2017.06.007.
